Cat.#: BBM-3C-062
Description | Collagens Type IV is derived from bovine tissue treated with pepsin. This product does not gel and needs to be mixed with collagen type I-A. |
Source | Bovine |
Size | 20 mL, 100 mL |
Form | Solution |
Sterility | Passed sterility test for bacteria and fungi. |
Concentration | 3.0 mg/mL |
Storage | 2-10℃ |
Shipping | Dry ice |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-068 | Cultrex Mouse Collagen IV |
Cultrex Mouse Collagen IV from Ace Therapeutics is a stromal extracellular matrix protein purified from a murine engelbreth-holm-swarm (EHS) tumor. This product can promote cell adhesion in cell and tissue cultures as well as be used as a hydrogel or thin coating for tissue culture vessels.
|
inquiry |
BBM-3C-030 | Bovine Collagen Type V (Atelocollagen), 1 mg |
Bovine Collagen Type V (Atelocollagen), 1 mg from Ace Therapeutics is purified from bovine placenta.
|
inquiry |
BBM-3C-064 | Collagen, Type I, from Rat Tail |
The rat tail collagen I provided by Ace Therapeutics is prepared according to the Birkedal-Hansen method through acetic acid extraction, sodium chloride precipitation, and disodium hydrogen phosphate precipitation. This product is derived from a rat tail, dissolved in 0.02M HAc solution, and the purity is greater than 90% as determined by SDS-PAGE, and it is sterile.
|
inquiry |
BBM-3C-053 | Mouse Collagen Type IV |
Collagen Type IV is a common component of the basement membrane. Mouse Collagen Type IV from Ace Therapeutics is a purified collagen derived from murine engelbreth-holm-swarm (EHS) tumor, and the product can be used to regulate cell growth, differentiation, and tissue formation.
|
inquiry |
BBM-3C-025 | Bovine Collagen Type I, 10 mg |
Bovine Collagen Type I, 10 mg from Ace Therapeutics is purified from bovine skin.
Type I collagen is found in connective tissues and is the major component of tensile strength of the extracellular matrix (ECM). The product is widely used as a thin layer on tissue-culture surfaces to enhance the attachment and proliferation of a variety of cells including endothelial cells, fibroblasts, hepatocytes, epithelial cells, etc. In addition, the product can self-assemble into a 3-D supramolecular gel in vitro as an ideal biological scaffold.
|
inquiry |
BBM-3C-069 | Cultrex Rat Collagen I |
Cultrex Rat Collagen I from Ace Therapeutics is a high concentration matrix extracellular matrix protein purified from rat tail tendon. This product is capable of polymerizing to form hydrogels and is a purified matrix ECM protein specifically designed and developed for 3D culture.
|
inquiry |
BBM-3C-052 | Human Collagen Type IV |
Collagen Type IV is a common component of the basement membrane. Human Collagen Type IV from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used to regulate cell growth, differentiation, and tissue formation.
|
inquiry |
BBM-3C-047 | Rat Tail Collagen Type I, Sterile, Filtered |
Rat Tail Collagen Type I, Sterile, Filtered, from Ace Therapeutics is a purified collagen derived from the rat tail. The Product can be used as a thin layer on tissue culture surfaces to enhance cell adhesion and proliferation, or as a glue layer to promote the expression of specific cell morphology and function. The product is typically used to culture endothelial cells, stem cells, muscle cells, and a variety of other cells.
|
inquiry |
BBM-3C-041 | Human Collagen Type IV |
Human Collagen Type IV from Human Cell Culture from Ace Therapeutics is derived from human placenta.
|
inquiry |
BBM-3C-056 | Porcine Gelatine |
Porcine Gelatine from Ace Therapeutics is a purified gelatin matrix from porcine tissue. The product can enhance the adsorption of various normal cells and transfected cells.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.